SCHEMBL3362495

SCHEMBL3362495

CCCCc1cc(C(F)(F)F)cc(CCCC)c1/C=C/C(=O)NC(C)c1cc(F)c(NS(C)(=O)=O)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 14/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL954563 1.00 TRPV1 (0.45) TRPV1
SCHEMBL954564 1.00 TRPV1 (0.45) TRPV1
SCHEMBL954566 1.00 TRPV1 (0.45) TRPV1
SCHEMBL12946132 0.95 TRPV1 (0.43) TRPV1
SCHEMBL953459 0.94 TRPV1 (0.41) TRPV1
SCHEMBL953457 0.94 TRPV1 (0.41) TRPV1
SCHEMBL12946085 0.94 TRPV1 (0.41) TRPV1
SCHEMBL953458 0.94 TRPV1 (0.41) TRPV1
SCHEMBL3364479 0.94 TRPV1 (0.41) TRPV1
SCHEMBL955729 0.92 TRPV1 (0.39) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2238105-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2010-10-13 EP disclosed
WO-2009096701-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2009-08-06 WO disclosed